Literature DB >> 9862072

Ethical and practical issues involved in behavioral pharmacology research that administers drugs of abuse to human volunteers.

M W Fischman1, C E Johanson.   

Abstract

Researchers carrying out non-therapeutic research that involves the administration of drugs of abuse to human volunteers can be faced with many ethical and practical questions. The history of this type of research is relatively brief, with little in the way of published information relevant to carrying out behavioral pharmacological research with human participants. The aim of this article is to raise issues that occur in most studies of this type and to provide solutions that we have found acceptable and which have been approved by a variety of institutions and regulatory agencies. Clearly, there are other approaches that would work equally as well, and we are not attempting to provide 'the' answer to many of the issues raised. We believe that raising these issues and providing our perspectives is important for stimulating others to discuss them and for all of us to strive, where possible, to reach a consensus concerning ethical practices and to become aware of gaps and pitfalls. The topics discussed range from the nuts and bolts of acquiring and keeping track of drugs, to selecting research participants and designing ethical studies that protect our volunteers while still collecting scientifically useful data.

Entities:  

Mesh:

Year:  1998        PMID: 9862072     DOI: 10.1097/00008877-199811000-00002

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  11 in total

Review 1.  Agonist replacement therapy for cocaine dependence: a translational review.

Authors:  Craig R Rush; William W Stoops
Journal:  Future Med Chem       Date:  2012-02       Impact factor: 3.808

Review 2.  Human hallucinogen research: guidelines for safety.

Authors:  Mw Johnson; Wa Richards; Rr Griffiths
Journal:  J Psychopharmacol       Date:  2008-07-01       Impact factor: 4.153

Review 3.  Cocaine choice procedures in animals, humans, and treatment-seekers: Can we bridge the divide?

Authors:  Scott J Moeller; William W Stoops
Journal:  Pharmacol Biochem Behav       Date:  2015-09-30       Impact factor: 3.533

4.  Substance use after participation in laboratory studies involving smoked cocaine self-administration.

Authors:  Raj K Kalapatapu; Gillinder Bedi; Margaret Haney; Suzette M Evans; Eric Rubin; Richard W Foltin
Journal:  Drug Alcohol Depend       Date:  2011-08-15       Impact factor: 4.492

5.  Reinforcing effects of d-amphetamine: influence of novel ratios on a progressive-ratio schedule.

Authors:  Rajkumar J Sevak; William W Stoops; Paul E A Glaser; Lon R Hays; Craig R Rush
Journal:  Behav Pharmacol       Date:  2010-12       Impact factor: 2.293

6.  A Brief Introduction to Human Behavioral Pharmacology: Methods, Design Considerations and Ethics.

Authors:  William W Stoops
Journal:  Perspect Behav Sci       Date:  2022-03-01

Review 7.  Controversies in translational research: drug self-administration.

Authors:  Margaret Haney; Roger Spealman
Journal:  Psychopharmacology (Berl)       Date:  2008-02-19       Impact factor: 4.530

Review 8.  Reinforcing effects of stimulants in humans: sensitivity of progressive-ratio schedules.

Authors:  William W Stoops
Journal:  Exp Clin Psychopharmacol       Date:  2008-12       Impact factor: 3.157

Review 9.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

10.  Pioglitazone, a PPARγ agonist, reduces nicotine craving in humans, with marginal effects on abuse potential.

Authors:  Jermaine D Jones; Sandra D Comer; Verena E Metz; Jeanne M Manubay; Shanthi Mogali; Roberto Ciccocioppo; Suky Martinez; Mudassir Mumtaz; Adam Bisaga
Journal:  Pharmacol Biochem Behav       Date:  2017-10-08       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.